QLi5 Therapeutics GmbH
PrivateLast Round
Corporate Funding
Dec 18, 2025
Total Funding Raised
$17.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
QLi5 Therapeutics GmbH is a biotechnology company that develops a next-generation platform of non-covalent proteasome inhibitors for the treatment of cancer, inflammatory, and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QLi5 Therapeutics GmbH Comparables
Compare QLi5 Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iProtics | 82% | |
| IpiNovyx Bio | 79% | |
| Johnson & Johnson | 73% | |
QLi5 Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 18, 2025 | ||||
| Series A | Sep 7, 2022 |
QLi5 Therapeutics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A |
| KTB Investment Group | Series A |
| Atinum Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$7.3M round led by Qurient Co. Ltd
QLi5 Therapeutics GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about QLi5 Therapeutics GmbH's valuation, stock price, and market status.